Guardant Health
GH
#1787
Rank
โ‚ฌ9.62 B
Marketcap
73,35ย โ‚ฌ
Share price
-3.96%
Change (1 day)
83.65%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Market capitalization of Guardant Health (GH)

Market cap: โ‚ฌ9.62 Billion

As of March 2026 Guardant Health has a market cap of โ‚ฌ9.62 Billion. This makes Guardant Health the world's 1787th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Guardant Health from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ9.62 B-15.49%
2025โ‚ฌ11.38 B215.01%
2024โ‚ฌ3.61 B21.69%
2023โ‚ฌ2.97 B14.34%
2022โ‚ฌ2.59 B-71.07%
2021โ‚ฌ8.97 B-14.29%
2020โ‚ฌ10.47 B59.92%
2019โ‚ฌ6.55 B132.46%
2018โ‚ฌ2.81 B

End of Day market cap according to different sources

On Mar 27th, 2026 the market cap of Guardant Health was reported to be:

โ‚ฌ9.62 Billion
by Nasdaq info icon info icon
โ‚ฌ9.62 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Neogen
NEOG
โ‚ฌ1.64 B-82.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
โ‚ฌ22.44 B 133.25%๐Ÿ‡บ๐Ÿ‡ธ USA